Products for Research Use Only
RegisterLogin

Fulzerasib

CAT: 0804-HY-152848-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-152848-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fulzerasib (GFH925) is an irreversible KRAS G12C inhibitor, has a synergistic anti-cancer effect with cetuximab.[1][2].
CAS Number
2641747-54-6
Product Name Alternative
IBI351; GFH925
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fulzerasib.html
Purity
99.60
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(C=C)N1CCN2C(C3=C(N4C5=C(C(C)C)N=CC=C5C)N=C(C6=C(O)C=CC=C6F)C(Cl)=C3)=C(N(C)C([C@@]2([H])C1)=O)C4=O
Molecular Formula
C32H30ClFN6O4
Molecular Weight
617.07
References & Citations
[1]Rafael Rosell, et al. KRAS G12C-mutant driven non-small cell lung cancer (NSCLC) . Crit Rev Oncol Hematol. 2024 Mar:195:104228.|[2]Vanesa Gregorc, et al. KROCUS: A phase II study investigating the efficacy and safety of fulzerasib. Free access.June 05, 2024
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
K-Ras

Alternative Products

CatalogName
T73190-01Fulzerasib
A24228-50Fulzerasib (IBI351, GFH925) 50mg
A24228-10Fulzerasib (IBI351, GFH925) 10mg
A24228-5Fulzerasib (IBI351, GFH925) 5mg
A24228-1Fulzerasib (IBI351, GFH925) 1mg

Popular Products